Cargando…
Predicting Clinical Dementia Rating Using Blood RNA Levels
The Clinical Dementia Rating (CDR) is commonly used to assess cognitive decline in Alzheimer’s disease patients and is included in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. We divided 741 ADNI participants with blood microarray data into three groups based on their most recent...
Autores principales: | Miller, Justin B., Kauwe, John S. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349260/ https://www.ncbi.nlm.nih.gov/pubmed/32604772 http://dx.doi.org/10.3390/genes11060706 |
Ejemplares similares
-
Dementia death rates prediction
por: Gaidai, Oleg, et al.
Publicado: (2023) -
Evaluation of the Electronic Clinical Dementia Rating for Dementia Screening
por: Nosheny, Rachel L., et al.
Publicado: (2023) -
Assembly of 809 whole mitochondrial genomes with clinical, imaging, and fluid biomarker phenotyping
por: Ridge, Perry G., et al.
Publicado: (2018) -
CUBAP: an interactive web portal for analyzing codon usage biases across populations
por: Hodgman, Matthew W, et al.
Publicado: (2020) -
Genome-wide association study of prolactin levels in blood plasma and cerebrospinal fluid
por: Staley, Lyndsay A., et al.
Publicado: (2016)